Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms

C Xu, X Ha, S Yang, X Tian, H Jiang - Frontiers in Endocrinology, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is a serious complication of diabetes that can lead to end-
stage kidney disease. Despite its significant impact, most research has concentrated on the …

NF-κB inducing kinase regulates intestinal immunity and homeostasis

B Wang, J Shen - Frontiers in Immunology, 2022 - frontiersin.org
Intestinal immunity and homeostasis are maintained through the regulation of cytokine
trafficking, microbiota, necrosis and apoptosis. Intestinal immunity and homeostasis …

Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy

JAC Portillo, A Pfaff, S Vos, M Weng, RH Nagaraj… - Cells, 2024 - mdpi.com
CD40 induces pro-inflammatory responses in endothelial and Müller cells and is required
for the development of diabetic retinopathy (DR). CD40 is upregulated in these cells in …

Serum sCD40L and IL-31 in association with early phase of IgA nephropathy

K Tanaka, H Sugiyama, H Morinaga… - Journal of clinical …, 2023 - mdpi.com
Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis
worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN …

Cytokine profile in patients with maturity-onset diabetes of the young (MODY)

A Diren, DK Demirci, N Gul, B Karacanli, A Baykut… - in vivo, 2022 - iv.iiarjournals.org
Abstract Background/Aim: High-sensitivity C-reactive protein (hs-CRP) is used in the
differential diagnosis of maturity-onset diabetes of the young (MODY)-3, but other …

TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts

K Stefania, KK Ashok, PV Geena, P Katarina, D Isak - Scientific Reports, 2024 - nature.com
Abstract Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite and TNF-α
is proinflammatory cytokine, both known to be associated with renal inflammation, fibrosis …

An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases

HH Wu, KL Ralph, E Sepuldeva, G Hansen, H Li… - International Journal of …, 2021 - Elsevier
Antibodies targeting the CD40-CD40L pathway have great potential for treating autoimmune
diseases like rheumatoid arthritis, systemic lupus erythematosus (SLE), lupus nephritis (LN) …

Potential role of soluble CD40 receptor in chronic inflammatory diseases

AH Wagner, A Klersy, CS Sultan, M Hecker - Biochemical Pharmacology, 2023 - Elsevier
The CD40 receptor and its ligand CD154 are widely expressed in various immune-
competent cells. Interaction of CD154 with CD40 is essential for B-cell growth …

Nongenetic forms of steroid-resistant nephrotic syndrome

MJ Kemper, K Gibson, A Sinha - Pediatric Nephrology, 2022 - Springer
Historically, the classification of steroid-resistant nephrotic syndrome (SRNS) was based on
histopathology alone, with minimal change disease and especially focal segmental …

Dysregulated CD40 and CD40 ligand expression in anti–N-methyl-d-aspartate receptor encephalitis

X Ma, C Chen, L Fang, X Zhong, Y Chang, R Li… - Journal of …, 2022 - Elsevier
Abstract Anti–N-methyl-d-aspartate receptor encephalitis (anti-NMDARE) is a B cell-and
antibody-mediated autoimmune disease which may be regulated by CD40/CD40L signaling …